Rollout Map
Sign Up
S. 1097 Senate Commerce

Interagency Patent Coordination and Improvement Act of 2025

Introduced
Mar 24, 2025
Sponsor
Sen. Durbin, Richard J. (D-IL)
View on Congress.gov

STAGE 3 OF 8 — CALENDARS AND SCHEDULING

Currently in the Senate. Last action: placed on senate legislative calendar under general orders. calendar no. 41 on Apr 10, 2025.

  1. Senate Introduced in Senate Mar 24, 2025
  2. Senate Read twice and referred to the Committee on the Judiciary. (text: CR S1804-1805) Mar 24, 2025
  3. Senate Committee on the Judiciary. Ordered to be reported with amendments favorably. Apr 3, 2025
  4. Senate Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report. Apr 10, 2025
  5. Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 41. Apr 10, 2025

Cosponsors

4

Subjects

Administrative remediesDepartment of CommerceDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Intellectual propertyIntergovernmental relations

Committees

  • Judiciary Committee
    • [Reported By, Apr 10, 2025]
    • [Markup By, Apr 3, 2025]
    • [Referred To, Mar 24, 2025]

Summary

Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

[Summary as of: Introduced in Senate]

Bill Text

Formatted Text PDF Formatted XML

Related Bills

  • Interagency Patent Coordination and Improvement Act of 2025 (Related bill)

Comments · 0

Loading comments...